RT Conference Proceedings
T1 Intracranial activity of encorafenib and binimetinib followed by radiotherapy in patients with BRAF mutated melanoma and brain metastasis: Preliminary results of the GEM1802/EBRAIN-MEL phase II clinical trial
A1 Marquez-Rodas, I.
A1 Arance, A.
A1 Berciano Guerrero, M. A.
A1 Diaz Beveridge, R.
A1 Alamo, M. D. C.
A1 Garcia Castano, A.
A1 Gonzalez Cao, M.
A1 Vidal, J.
A1 Puertolas Hernandez, T.
A1 Soria, A.
A1 Aguado De la Rosa, C.
A1 Sanchez Maurino, P.
A1 Valduvieco, I.
A1 Delgado Rico, R.
A1 Conde, A.
A1 Foro, P.
A1 Prada, P. J.
A1 Puertas, E.
A1 Alvarez Gonzalez, A.
A1 Berrocal, A.
PB Elsevier
SN 0923-7534
YR 2021
FD 2021-09-21
LK https://hdl.handle.net/10668/25882
UL https://hdl.handle.net/10668/25882
LA en
DS RISalud
RD Apr 12, 2025